Navigating the Meandering Path of Oncology Drug Development
At the AACR Annual Meeting 2025, experts offered strategies on how to overcome the challenges within the oncology drug...
Author:
Neha J. Pancholi, PhD
At the AACR Annual Meeting 2025, experts offered strategies on how to overcome the challenges within the oncology drug...
The latest edition of From the Bench features creative cancer research, including making tumors seem like pig organs, starving...
Learn how a Gleason score is calculated to help determine the aggressiveness of prostate cancer, and how it could...
At the AACR Annual Meeting 2025, a session on artificial intelligence in cancer care included ways of detecting skin...
A recently approved first-line therapy and novel insights into optimizing treatment strategies may offer new options for esophageal cancer...
Cancer screenings are key to saving lives. Take colonoscopies, for example, which are estimated to reduce colorectal cancer risk...
Researchers are examining ways to make treatments more targeted to each type of biliary tract cancer or to each...
At the 2024 San Antonio Breast Cancer Symposium, researchers discussed clinical trials for vaccines and other ways to prevent...
Researchers at the 2024 San Antonio Breast Cancer Symposium discussed considerations for treating and managing of early-onset breast cancer.
When the chemotherapy drug 5-fluorouracil (5-FU) was approved in 1962, there was limited understanding of how it is metabolized...